Key result
Systematic use of compound motor action potential monitoring during cryoballoon-based pulmonary vein isolation resulted in a 1% incidence of persistent phrenic nerve injury, with all cases preceded by a reduction in CMAP amplitude.
Why the study?
Phrenic nerve injury remains a frequent complication of CB-PVI, and while compound motor action potential monitoring is increasingly used for prevention, systematic outcome data are sparse.
Does systematic compound motor action potential (CMAP) monitoring prevent phrenic nerve injury in patients with atrial fibrillation undergoing cryoballoon-based pulmonary vein isolation?
Observational (n=388)
No
Does systematic compound motor action potential (CMAP) monitoring prevent phrenic nerve injury in patients with atrial fibrillation undergoing cryoballoon-based pulmonary vein isolation?
Systematic use of CMAP monitoring during cryoballoon-based pulmonary vein isolation is reliable and associated with a low incidence of persistent phrenic nerve injury (1%).
CMAP monitoring was associated with low persistent PNI rates; leaves open whether it prevents injury without randomized data.
BACKGROUND: Phrenic nerve injury (PNI) remains one of the most frequent complications during cryoballoon-based pulmonary vein isolation (CB-PVI). Since its introduction in 2013, the use of compound motor action potential (CMAP) for the prevention of PNI during CB-PVI is increasing; however, systematic outcome data are sparse. METHODS: The CMAP technique was applied in conjunction with abdominal palpation during pacing manoeuvres (10 mV, 2 ms) from the superior vena cava for 388 consecutive patients undergoing CB-PVI between January 2015 and May 2017 at our tertiary arrhythmia centre. Cryoablation was immediately terminated when CMAP amplitude was reduced by 30%. RESULTS: Reductions in CMAP amplitude were observed in 16 (4%) of 388 patients during isolation of the right veins. Of these, 11 (69%) patients did not manifest a reduction in diaphragmatic excursions. The drop in CMAP amplitude was observed in 10 (63%) patients during ablation of the right superior pulmonary veins (PVs) and in 7 (44%) patients during ablation of the right inferior PVs. Postprocedural persistent PNI was observed in three of four patients for a duration of 6 months, with one of these patients remaining symptomatic at the 24-month follow-up. One of the four patients was lost to long-term follow-up. CONCLUSIONS: All PNIs occurred during right-sided CB-PVI and were preceded by a reduction in CMAP amplitude. Thus, the standardized use of CMAP surveillance during CB-PVI is easily applicable, reliable and compared with other studies, results in a lower number of PNIs.
No takes yet. Share an insight, caveat, or question.
Anwar et al. (2020) conducted an observational in Atrial fibrillation (n=388). Compound motor action potential (CMAP) monitoring was evaluated on Persistent phrenic nerve injury. Systematic use of compound motor action potential monitoring during cryoballoon-based pulmonary vein isolation resulted in a 1% incidence of persistent phrenic nerve injury, with all cases preceded by a reduction in CMAP amplitude.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: